Eplerenone reduces risk of cardiovascular death or hospitalisation in heart failure patients with reduced ejection fraction
- PMID: 21558564
- DOI: 10.1136/ebm1307
Eplerenone reduces risk of cardiovascular death or hospitalisation in heart failure patients with reduced ejection fraction
Comment on
-
Eplerenone in patients with systolic heart failure and mild symptoms.N Engl J Med. 2011 Jan 6;364(1):11-21. doi: 10.1056/NEJMoa1009492. Epub 2010 Nov 14. N Engl J Med. 2011. PMID: 21073363 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources